Danimarka -
Danca -
Lægemiddelstyrelsen (Danish Medicines Agency)
methylphenidate "orifarm" 10 mg kapsler med modificeret udløsning, hårde
orifarm generics a/s - methylphenidathydrochlorid - kapsler med modificeret udløsning, hårde - 10 mg
Danimarka -
Danca -
Lægemiddelstyrelsen (Danish Medicines Agency)
methylphenidat "orifarm" 27 mg depottabletter
orifarm a/s - methylphenidathydrochlorid - depottabletter - 27 mg
Danimarka -
Danca -
Lægemiddelstyrelsen (Danish Medicines Agency)
methylphenidat "2care4" 18 mg depottabletter
2care4 aps - methylphenidathydrochlorid - depottabletter - 18 mg
Danimarka -
Danca -
Lægemiddelstyrelsen (Danish Medicines Agency)
methylphenidate "mylan" 18 mg depottabletter
mylan ab - methylphenidathydrochlorid - depottabletter - 18 mg
Danimarka -
Danca -
Lægemiddelstyrelsen (Danish Medicines Agency)
methylphenidate "sandoz" 18 mg depottabletter
sandoz a/s - methylphenidathydrochlorid - depottabletter - 18 mg
Avrupa Birliği -
Danca -
EMA (European Medicines Agency)
dimethyl fumarate mylan
mylan ireland limited - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Avrupa Birliği -
Danca -
EMA (European Medicines Agency)
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Avrupa Birliği -
Danca -
EMA (European Medicines Agency)
dimethyl fumarate teva
teva gmbh - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Avrupa Birliği -
Danca -
EMA (European Medicines Agency)
dimethyl fumarate accord
accord healthcare s.l.u. - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Danimarka -
Danca -
Lægemiddelstyrelsen (Danish Medicines Agency)
methylphenidate "hexal" 36 mg depottabletter
hexal a/s - methylphenidathydrochlorid - depottabletter - 36 mg